Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer’s Disease and Multiple SclerosisAinhoa Etxeberría, Christopher J. Bohlen, Alicia Nugent et al.|Journal of Neuroscience|2024Cited by 28